Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Schistosomiasis vaccine SchistoShield® induces functional immune memory responses in US and African populations.

NPJ vaccines·2026
Same author

Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Disease: Primary Aggregated Analysis of All Baskets from the Phase II Randomized EXTEND Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial.

Nature communications·2026
Same author

Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis.

The oncologist·2026
Same author

Correction: Navigating drug-drug interactions with apalutamide.

Prostate cancer and prostatic diseases·2026
Same author

The path forward for T cell engagers in patients with prostate cancer.

Journal for immunotherapy of cancer·2026
Same journal

Court finds no Vaccines-autism link.

Human vaccines·2022
Same journal

Introduction of a second dose of measles in national immunization program in India: a major step towards eradication.

Human vaccines·2012
Same journal

Vaccination against trypanosomiasis: can it be done or is the trypanosome truly the ultimate immune destroyer and escape artist?

Human vaccines·2011
Same journal

Immune response to influenza vaccination in children treated with methotrexate or/and tumor necrosis factor-alpha inhibitors.

Human vaccines·2011
Same journal

Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.

Human vaccines·2011
Same journal

Fighting against infectious diseases in China.

Human vaccines·2011
See all related articles

Related Experiment Video

Updated: May 27, 2026

Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules
05:30

Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules

Published on: August 16, 2011

Schistosomiasis vaccines.

Afzal A Siddiqui1, Bilal A Siddiqui, Lisa Ganley-Leal

  • 1Department of Microbiology and Immunology, Internal Medicine, Pathology, Texas Tech University Health Sciences Center, Lubbock, TX USA. Afzal.Siddiqui@ttuhsc.edu

Human Vaccines
|November 4, 2011
PubMed
Summary
This summary is machine-generated.

Developing a schistosomiasis vaccine is crucial for controlling this neglected tropical disease. A successful vaccine could provide long-term immunity, reduce parasite load, and prevent severe infections in at-risk children.

More Related Videos

A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

Mass Isolation and In Vitro Cultivation of Intramolluscan Stages of the Human Blood Fluke Schistosoma Mansoni
12:05

Mass Isolation and In Vitro Cultivation of Intramolluscan Stages of the Human Blood Fluke Schistosoma Mansoni

Published on: January 14, 2018

Related Experiment Videos

Last Updated: May 27, 2026

Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules
05:30

Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules

Published on: August 16, 2011

A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

Mass Isolation and In Vitro Cultivation of Intramolluscan Stages of the Human Blood Fluke Schistosoma Mansoni
12:05

Mass Isolation and In Vitro Cultivation of Intramolluscan Stages of the Human Blood Fluke Schistosoma Mansoni

Published on: January 14, 2018

Area of Science:

  • Tropical medicine
  • Vaccinology
  • Parasitology

Background:

  • Schistosomiasis is a major neglected tropical disease affecting a billion people globally.
  • Despite control efforts, the disease remains prevalent and is spreading geographically.
  • Current interventions have not fully contained schistosomiasis.

Purpose of the Study:

  • To review the current status of vaccine development for schistosomiasis.
  • To highlight the potential of a protective vaccine for disease control.
  • To discuss the benefits of a vaccine in reducing morbidity and parasite transmission.

Main Methods:

  • This is a review article, summarizing existing research and development in schistosomiasis vaccine initiatives.
  • The review analyzes the immunological mechanisms targeted by vaccine candidates.
  • It assesses the potential impact of a vaccine on disease burden and public health.

Main Results:

  • Vaccine development remains the most promising strategy for effective schistosomiasis control.
  • A successful vaccine could induce long-term immunity, reduce parasite burden, and decrease egg production.
  • Vaccination of children aged 3-12 years could prevent severe disease in a high-risk population.

Conclusions:

  • A schistosomiasis vaccine holds significant potential for disease eradication and public health improvement.
  • Further research and development are essential to bring a protective vaccine to fruition.
  • Vaccination strategies could complement existing control measures for comprehensive schistosomiasis management.